Burning Rock Biotech Ltd (BNR) › Cost of RevenueBurning Rock Biotech Ltd (BNR) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2018: 73.81M CNY2019: 108.34M CNY2020: 115.98M CNY2021: 143.72M CNY2022: 183.20M CNY2023: 174.21M CNY2024: 153.42M CNY2025: 136.65M CNY136.65M CNY2018Cost of Revenue (CNY)2025Fiscal YearCost of RevenueChange YoY2025136.65M CNY-10.9%2024153.42M CNY-11.9%2023174.21M CNY-4.9%2022183.20M CNY+27.5%2021143.72M CNY+23.9%2020115.98M CNY+7.0%2019108.34M CNY+46.8%201873.81M CNY—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share